Literature DB >> 32869512

Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: A systematic review and meta-analysis of prospective cohort studies.

Jacob Opio1, Emma Croker2, George S Odongo3, John Attia1,4, Katie Wynne1,2,4, Mark McEvoy1,4.   

Abstract

This review examined the risk of cardiovascular disease in adults with metabolically healthy overweight/obesity. A systematic review and meta-analysis using data from Medline, EMBASE, SCOPUS and Cochrane Library searched from inception up to 31st October 2019. We included prospective cohort studies of adults who are metabolically healthy or unhealthy. Outcomes were fatal and nonfatal cardiovascular events, all-cause mortality. Pooled relative risk was calculated for each outcome in populations with metabolically healthy overweight and metabolically healthy obesity using metabolically healthy normal weight as reference. A random-effects model was used for meta-analysis, and risk of bias assessment tool for nonrandomized studies assessed risk of bias within each study. Twenty-three prospective cohort studies with 4,492,723 participants were included. Cardiovascular disease risk was increased in metabolically healthy groups with overweight (RR = 1.34, CI: 1.23-1.46, n = 20, I2 = 90.3%) and obesity (RR = 1.58, CI: 1.34-1.85, n = 21, I2 = 92.2) compared with a reference group with metabolically healthy normal weight. Cardiovascular disease risk was similar irrespective of the number of risk factors used to define metabolically healthy and the risk remained in the group with no metabolic risk factors. Cardiovascular disease risk is increased in populations with overweight and obesity classified as metabolically healthy even when there were no metabolic risk factors.
© 2020 World Obesity Federation.

Entities:  

Keywords:  cardiovascular disease; metabolic health; obesity; overweight

Year:  2020        PMID: 32869512     DOI: 10.1111/obr.13127

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  16 in total

Review 1.  Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure.

Authors:  Eduardo Thadeu de Oliveira Correia; Jeffrey I Mechanick; Letícia Mara Dos Santos Barbetta; Antonio José Lagoeiro Jorge; Evandro Tinoco Mesquita
Journal:  Heart Fail Rev       Date:  2022-04-04       Impact factor: 4.214

2.  Effect of a 1-Year Controlled Lifestyle Intervention on Body Weight and Other Risk Markers (the Healthy Lifestyle Community Programme, Cohort 2).

Authors:  Christian Koeder; Ragna-Marie Kranz; Corinna Anand; Sarah Husain; Dima Alzughayyar; Nora Schoch; Andreas Hahn; Heike Englert
Journal:  Obes Facts       Date:  2021-12-17       Impact factor: 4.807

Review 3.  Synergizing Mouse and Human Studies to Understand the Heterogeneity of Obesity.

Authors:  Penny Gordon-Larsen; John E French; Naima Moustaid-Moussa; Venkata S Voruganti; Elizabeth J Mayer-Davis; Christopher A Bizon; Zhiyong Cheng; Delisha A Stewart; John W Easterbrook; Saame Raza Shaikh
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 11.567

4.  Trends in Obesity and Metabolic Status in Northern and Southern China Between 2012 and 2020.

Authors:  Ying Li; Lin Yang; Lu Yin; Qingqi Liu; Yaqin Wang; Pingting Yang; Jiangang Wang; Zhiheng Chen; Xiaohui Li; Qinyu Yang; Yongmei He; Xin Huang
Journal:  Front Nutr       Date:  2022-01-11

5.  Obesity, metabolic risk and adherence to healthy lifestyle behaviours: prospective cohort study in the UK Biobank.

Authors:  Laura Heath; Susan A Jebb; Paul Aveyard; Carmen Piernas
Journal:  BMC Med       Date:  2022-02-15       Impact factor: 8.775

6.  Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.

Authors:  Vilde Lehne Michalsen; Sarah H Wild; Kirsti Kvaløy; Johan Svartberg; Marita Melhus; Ann Ragnhild Broderstad
Journal:  BMC Cardiovasc Disord       Date:  2021-10-21       Impact factor: 2.298

Review 7.  Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis.

Authors:  Hassan Okati-Aliabad; Alireza Ansari-Moghaddam; Shiva Kargar; Neda Jabbari
Journal:  J Obes       Date:  2022-02-03

8.  Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients.

Authors:  Egidio Imbalzano; Giuseppina T Russo; Annalisa Giandalia; Angela Sciacqua; Luana Orlando; Vincenzo Russo; Maria Perticone; Arrigo F G Cicero; Antonio Giovanni Versace; Pierpaolo Di Micco; Vincenzo Antonio Ciconte; Giuseppe Dattilo; Giovanni Squadrito; Marco Vatrano
Journal:  Biomedicines       Date:  2022-02-10

9.  A Bayesian Network Analysis of the Probabilistic Relationships Between Various Obesity Phenotypes and Cardiovascular Disease Risk in Chinese Adults: Chinese Population-Based Observational Study.

Authors:  Simiao Tian; Mei Bi; Yanhong Bi; Xiaoyu Che; Yazhuo Liu
Journal:  JMIR Med Inform       Date:  2022-03-02

10.  Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.

Authors:  Stefan Grudén; Anders Forslund; Göran Alderborn; Arvid Söderhäll; Per M Hellström; Ulf Holmbäck
Journal:  Clin Pharmacol Drug Dev       Date:  2021-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.